Evidence map›Paper›PMID 32822545›Full record

ReviewThe British journal of radiology2020

What's New for Clinical Whole-body MRI (WB-MRI) in the 21st Century.

Nina Tunariu, Matthew Blackledge, Christina Messiou, Giuseppe Petralia, Anwar Padhani, Sebastian Curcean, Andra Curcean, Dow-Mu Koh

Abstract readHistorical ArticleReview
In one paragraph

Review in The British journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nina TunariuDepartment of Radiology, Royal Marsden Hospital, Downs Road, Sutton, London, UK.ORCID http://orcid.org/0000-0001-6656-3699
Matthew BlackledgeDepartment of Radiotherapy, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, UK.
Christina MessiouDepartment of Radiology, Royal Marsden Hospital, Downs Road, Sutton, London, UK.
Giuseppe PetraliaDepartment of Radiology, European Institute of Oncology, Via Ripamonti, 435 - 20141 Milan, Italy.
Anwar PadhaniMount Vernon Hospital, The Paul Strickland Scanner Centre, Rickmansworth Road, Northwood, Middlesex, UK.
Sebastian CurceanDepartment of Radiology, Royal Marsden Hospital, Downs Road, Sutton, London, UK.
Andra CurceanDepartment of Radiology, Royal Marsden Hospital, Downs Road, Sutton, London, UK.
Dow-Mu KohDrug Development Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-body MRI (WB-MRI) has evolved since its first introduction in the 1970s as an imaging technique to detect and survey disease across multiple sites and organ systems in the body. The development of diffusion-weighted MRI (DWI) has added a new dimension to the implementation of WB-MRI on modern scanners, offering excellent lesion-to-background contrast, while achieving acceptable spatial resolution to detect focal lesions 5 to 10 mm in size. MRI hardware and software advances have reduced acquisition times, with studies taking 40-50 min to complete.The rising awareness of medical radiation exposure coupled with the advantages of MRI has resulted in increased utilization of WB-MRI in oncology, paediatrics, rheumatological and musculoskeletal conditions and more recently in population screening. There is recognition that WB-MRI can be used to track disease evolution and monitor response heterogeneity in patients with cancer. There are also opportunities to combine WB-MRI with molecular imaging on PET-MRI systems to harness the strengths of hybrid imaging. The advent of artificial intelligence and machine learning will shorten image acquisition times and image analyses, making the technique more competitive against other imaging technologies.

Indexed as

Genetic Predisposition to DiseaseDiffusion Magnetic Resonance ImagingFemaleHistory, 21st CenturyHumansIncidental FindingsMagnetic Resonance ImagingMaleMultimodal ImagingNeoplasmsPositron-Emission TomographyRadiation ExposureTime FactorsWhole Body Imaging

Identifiers

PMID32822545
PMCPMC8519652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.